News
hapabapa The U.S. Food and Drug Administration on Thursday approved ziftomenib (Komzifti), a leukemia drug developed by Kura Oncology (KURA) with Japanese drugmaker Kyowa…
MiMedx raises full-year revenue growth outlook to low double digits as momentum builds post-record quarter
The Paramount-Skydance deal could open the door for a membership change, but Robinhood and AppLovin…
Handset and automotive revenue came up short, but Qualcomm’s CFO says the company is in…
StockGood/iStock via Getty ImagesInvestment firm KKR (NYSE:KKR) and Energy Capital Partners, one of the largest…
A provision in the Republican megabill, which was signed into law earlier this month, giving…
After a rough go of it in 2025, the U.S. dollar has recently experienced a…
Advertisement
